125
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Different outcomes of methadone maintenance therapy in rehabilitated and relapsed drug addicts: significance of liver and renal biomarkers

ORCID Icon, ORCID Icon & ORCID Icon
Pages 470-475 | Received 11 Nov 2019, Accepted 14 Jan 2020, Published online: 03 Feb 2020

References

  • Abbasi, N., et al., 2017. Investigating the methadone effects of AST, ALT, and ALP enzymes of serum of male Wistar rats. Indo American Journal of Pharmaceutical Sciences, 4 (12), 4243–4247.
  • Adeva-Andany, M., et al., 2014. Comprehensive review on lactate metabolism in human health. Mitochondrion, 17, 76–100.
  • Aghabiklooei, A., et al., 2014. Prognostic factors in acute methadone toxicity: a 5-year study. Journal of Toxicology, 6, 341826.
  • Alcaraz, S., et al., 2018. Heroin-dependent patient satisfaction with methadone as a medication influences satisfaction with basic interventions delivered by staff to implement methadone maintenance treatment. Patient Preference and Adherence, 12, 1203–1211.
  • Alessio, L., et al., 1985. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. International Archives of Occupational and Environmental Health, 55 (2), 99–106.
  • Amraei, M., et al., 2018. Histopathological study of liver tissue due to methadone consumption and its effect on liver enzymes and inflammatory indices in rat. Drug Design, Development and Therapy, 12, 3785–3795.
  • Barbosa Neto, J.O., Garcia, M.A., and Garcia, J.B.S., 2015. Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication. Revista Dor, 16 (1), 60–66.
  • Bolz, J., et al., 2015. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. Journal of the Neurological Sciences, 356 (1–2), 193–195.
  • Chan, Y.Y., et al., 2015. Inflammatory response in heroin addicts undergoing methadone maintenance treatment. Psychiatry Research, 226 (1), 230–234.
  • Cicero, T.J., Ellis, M.S., and Kasper, Z.A., 2017. Increased use of heroin as an initiating opioid of abuse. Addictive Behaviors, 74, 63–66.
  • Cicero, T.J., et al., 2014. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71 (7), 821–826.
  • Crawford, R.M., et al., 2002. M-LDH serves as a sarcolemmal KATP channel subunit essential for cell protection againstischemia. The EMBO Journal, 21 (15), 3936–3948.
  • Dean, M., 2004. Opioids in renal failure and dialysis patients. Journal of Pain and Symptom Management, 28 (5), 497–504.
  • Elnimr, T., Hashem, A., and Assar, R., 1996. Heroin dependence effects on some major and trace elements. Biological Trace Element Research, 54 (2), 153–162.
  • Eslami-Shahrbabaki, M., et al., 2012. Effects of methadone on liver enzymes in patients undergoing methadone maintenance treatment. Addiction and Health, 4 (3–4), 111–116.
  • European Drug Report. 2014. Trends and Developments. Luxembourg: Publications Office of the European Union.
  • Farooqi, S., et al., 2016. Effect of heroin use on liver enzymes. Journal of Advances in Biology and Biotechnology, 5 (1), 1–9.
  • Gabbe, S., et al., 2007. Obstetrics: normal and problem pregnancies. 7th ed. Philadelphia, PA: Elsevier.
  • Gerber, J.G., Rhodes, R.J., and Gal, J., 2004. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality, 16 (1), 36–44.
  • Golub, E., and Boesze-Battaglia, K., 2007. The role of alkaline phosphatase in mineralization. Current Opinion in Orthopaedics, 18 (5), 444–448.
  • Gramenz, P., Roberts, D., and Schrag, L., 2010. Intra-arterial self-injection of methadone tablets into the femoral artery. Journal of Emergency Medicine, 39 (3), 125–127.
  • Guzel, D., et al., 2018. Evaluation of immunomodulatory and hematologic cell outcome in heroin/opioid addicts. Journal of Addiction, 2018, 1–8.
  • Hawks, R. L., 1983. Developments in cannabinoid analyses of body fluids: implications for forensic applications. In: S. Agurell, W. Dewey, R. Willette, eds. The cannabinoids: chemical, pharmacologic and therapeutic aspects. Rockville, MD: Academic Press, 1–12.
  • Hojs, R., and Sinkovic, A., 1992. Rhabdomyolysis and acute renal failure following methadone abuse. Nephron, 62 (3), 362–362.
  • Huestis, M.A., and Cone, E.J., 1998. Differentiating new marijuana use from residual drugexcretion in occasional marijuana users. Journal of Analytical Toxicology, 22 (6), 445–454.
  • Jovanovic, S., Jovanovic, A., and Crawford, R.M., 2007. M-LDH serves as a regulatory subunit of the cytosolic substrate-channelling complex in vivo. Journal of Molecular Biology, 371 (2), 349–361.
  • Kim, T.W., et al., 2006. Low bone density in patients receiving methadone maintenance treatment. Drug and Alcohol Dependence, 85 (3), 258–262.
  • Kreek, M.J., 1973. Medical safety and side effects of methadone in tolerant individuals. JAMA: The Journal of the American Medical Association, 223 (6), 665–668.
  • Kreek, M.J., et al., 1980. Methadone use in patients with chronic renal disease. Drug and Alcohol Dependence, 5 (3), 197–205.
  • Lankenau, S.E., et al., 2012. Initiation into prescription opioid misuse amongst young injection drug users. International Journal of Drug Policy, 23 (1), 37–44.
  • Mehić-Basara, N., Hasečić, H., Pokrajac, M., and Selman, S., 2014. A guide to methadone use in opiate addicts. Sarajevo: Institute for Alcoholism and Other Toxicomania of Sarajevo Canton, Ministry of Health of Sarajevo Canton, 18–25.
  • Nilsson, M.I., et al., 1982. Effect of urinary pH on the disposition of methadone in man. European Journal of Clinical Pharmacology, 22 (4), 337–342.
  • Pogromov, A.P., Mishnaevskiĭ, A.L., and Mustain, K.H., 2002. Viral liver damage in heroin abusers. Experimental and Clinical Gastroenterology, 1, 61–63.
  • Psychoactive Substances Act. 2016. CHAPTER 2: An Act to make provision about psychoactive substances; and for connected purposes. London, UK: EU Legislation and UK Public General Acts.
  • Saxon, A.J., et al., 2013. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. Journal of Food and Drug Analysis, 21 (4), 69–72.
  • Soyka, M., and Müller, C.A., 2017. Pharmacotherapy of alcoholism – an update on approved or available medications. Expert Opinion on Pharmacotherapy, 18 (12), 1187–1199.
  • Suljevic, D., Mehinovic, L., and Alijagic, A., 2016. Hepatitis and biochemical markers in correlation with alpha-fetoprotein as a diagnostic indicator for the HBV and HCV differentiation. Albanian Medical Journal, 3, 13–20.
  • Sullivan, L.E., et al., 2005. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction, 100 (2), 150–158.
  • Tong, M.J., and el-Farra, M.S., 1996. Clinical sequelae of hepatitis C acquired from injection drug use. The Western Journal of Medicine, 164 (5), 399–404.
  • Uhl, G.R., and Grow, R.W., 2004. The burden of complex genetics in brain disorders. Archives of General Psychiatry, 61 (3), 223–229.
  • Vale, A., 2007. Rhabdomyolysis. Medicine, 35 (10), 554–555.
  • Valga-Amado, F., et al., 2012. Rhabdomyolysis with acute renal failure secondary to taking methadone. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia, 32 (2), 262–263.
  • Varenbut, M., et al., 2010. Does low urine creatinine level indicate the presence of urine alcohol in methadone maintenance treatment patients? The American Journal of Drug and Alcohol Abuse, 36 (4), 199–201.
  • Walters, G.O., Miller, F.M., and Worwood, M., 1973. Serum ferritin concentration and iron stores in normal subjects. Journal of Clinical Pathology, 26 (10), 770–772.
  • Ward, J., Hall, W., and Mattick, R.P., 1999. Role of maintenance treatment in opioid dependence. The Lancet, 353 (9148), 221–226.
  • Welsh, C., and Valadeaz-Meltzer, A., 2005. Buprenorphine: a (relatively) new treatment for opioid dependence. Psychiatry (Edgmont), 2 (12), 29–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.